
    
      PRIMARY OBJECTIVE:

      I. To determine the proportion of high risk patients who perceive receiving a prescription of
      intranasal naloxone to be beneficial for them.

      SECONDARY OBJECTIVES:

      I. To determine the proportion of caregivers who perceive receiving a prescription of
      intranasal naloxone to be beneficial for the patient.

      II. To determine the association between high risk patients' and their caregivers'
      characteristics (this includes cut-annoyed-guilty-eye [CAGE], screener and opioid assessment
      for patients with pain [SOAPP], age, gender, ethnicity, education, employment status,
      presence of caregiver, cancer type, cancer stage, reason for Narcan prescription, health
      insurance, and setting of Narcan prescription) and their perception that a prescription for
      intranasal naloxone is beneficial for patients.

      EXPLORATORY OBJECTIVE:

      I. To conduct an exploratory analysis of high risk patients' and caregivers' attitudes and
      beliefs regarding prescription of intranasal naloxone spray.

      OUTLINE:

      Participants complete a survey over 30 minutes.
    
  